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helpful to identify the consequences of ethnic allele vari-ntroduction
heumatoid arthritis (RA) is the most common chronic inﬂam-
atory disease, characterized by autoantibody formation and
rogressive joint destruction. In RA, synovial membrane pri-
arily gets affected but it can affect other organs as well.1
A is a devastating and common disease having prevalence
f approximately 1% in world population, and 0.14–0.3% Pak-
stani population, with women affected three times more
ften than men.2 The exact etiology of RA is yet unknownPlease cite this article in press as: John P, et al. Case–control study of vitam
patients. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2015.07.
ut it depends on the interaction of number of environmental
nd genetic factors.3 In recent years starring role of vitamin D,
 secosteroid hormone carries out the activities through VDR
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icenses/by-nc-nd/4.0/).and VDR itself has been found in immunomodulation, thus we
selected the gene VDR to investigate its impact in RA suscep-
tibility. The VDR protein is translated from VDR gene which is
extremely polymorphic. The four important VDR gene vari-
ants, rs2228570 in exon 2, rs1544410, rs7975232 in intron 8
and rs731236 in exon 9 have been widely studied and are also
known to be associated with autoimmune diseases includ-
ing systemic lupus erythematosus, Addison’s disease, type I
diabetes and RA.4
Study of differences in genotype distribution would bein D receptor gene polymorphism in Pakistani rheumatoid arthritis
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ation because of distinct genetic backgrounds, additionally
have unlike environmental elements. It also helps in interpre-
ting and detecting phenotypic variability in terms of disease
e under the CC BY-NC-ND license (http://creativecommons.org/
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Table 1 – General characteristics of population studied.
Characteristics Cases (n = 100) Control (n = 100)
Male 37 31
of vitamin D 1,25[OH2]D binds to VDR which then moveFemale 63 69
Age (mean) 44.2 43
severity. Based on genotype distinctions, biological inter-
pretation could be claimed by disease association studies.
Polymorphism rs1544410 located in intron 8 near 3′ UTR
region, affects the VDR gene transcription level, transcript
stability and post transcriptional modiﬁcations.5 Some pre-
viously reported data showed functional signiﬁcance in the
distribution of rs1544410 genotype, our study was accompa-
nied to evaluate the association of VDR polymorphism with
RA in our group of study. There is a great need to discover the
potential genetic risk markers of RA susceptibility, in our Pak-
istani population, but no such work have previously been done
for Pakistani RA patients.
Materials  and  methods
A total of 100 patients and 100 healthy controls (non-
symptomatic individuals) matched for age and sex (Table 1)
were recruited for this case–control study. Patients fulﬁlling
the 2011 classiﬁcation criteria of the American College of
Rheumatology (ACR-2011) were diagnosed by rheumatologists
from Rehmat Noor Clinic, Rawalpindi, working in collabora-
tion with our research group. The study was approved by
Institutional Review Board (IRB) of ASAB-NUST, following the
rules of the Declaration of Helsinki and the informed consent
was taken. Blood samples of all the included RA patients as
well as from the healthy controls were collected in 0.5 M EDTA
(ethylenediaminetetraacetic acid) tubes. SNP that causes sin-
gle nucleotide change from major allele frequency guanine
(G) to minor allele frequency adenine (A) was investigated to
check the presence of polymorphism in our study group.
Genomic DNA was extracted from collected blood sam-
ples using phenol–chloroform method, quantiﬁed by nan-
odrop (eppendrof Biophotometer Plus). Manually designed
two forward and a common reverse primer (VDR-F1-
5′GCCACAGACAGGCCTGCG3′, VDR-F2-5′GCCACAGACAGGCC-
TGCA3′, VDR-R-5′GTCACTGCACATTGCCTCCAA3′) were usedPlease cite this article in press as: John P, et al. Case–control study of vitam
patients. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2015.07.
for VDR gene non-coding variant (rs1544410) genotyp-
ing through Ampliﬁcation Refractory Mutation System-
Polymerase Chain Reaction (ARMS-PCR). PCR products were
Table 2 – Genotype and allele frequencies distribution in cases 
Genotype Genotype frequencies X2 statistics All
Cases
(n = 100)
Control
(n  = 100)
X2 value df p-value
(alpha <0.05)
GG 31.0 40.0
5.662 2 0.0590
G
GA 50.0 52.0
AA 19.0 8.0 A
df, degree of freedom. 1 6;x  x x(x x):xxx–xxx
resolved on 2% agarose gel after ampliﬁcation in 96 wells
thermocycler 2720 (Applied Biosystems). Statistical analy-
sis was performed using Graphpad Prism 6V software, Chi
square (X2) and two-tailed Fisher’s exact tests were applied for
association analysis of rs1544410 polymorphism in our study
population. Odds ratio (OR) with 95% conﬁdence interval was
calculated and p value <0.05 was considered statistically sig-
niﬁcant.
Results
Hardy–Weinberg equilibrium (HWE) calculations made for
control group shows no signiﬁcant difference between
observed values and the expected values, with the p-value
of 0.0034 and showed to be in HWE. This indicates that
there was no signiﬁcant drift in observed allele frequencies of
patients, when compared with controls, thus both the groups
were suitable for further analysis and association studies. The
frequency of all possible genotypes did not also show any sig-
niﬁcant difference in patients and healthy individuals (Table 2
and Fig. 1A). The value of X2 was found to be 5.662 with a
probability of error (p-value) of 0.0590. Allele frequencies for
RA patients were also not signiﬁcantly different from con-
trols (Table 2 and Fig. 1B). The observed results indicated no
signiﬁcant association between the SNP and RA. Thus, the
data nulliﬁed any signiﬁcant association of VDR gene polymor-
phism with RA in our group of study. Sex speciﬁc association
with rs1544410 was also carried out but no signiﬁcant associa-
tion has been shown between RA affected females and males
(data not shown).
Discussion
In the recent years gene polymorphism has been one of the
utmost discussed topic of genomic variations. RA is a systemic
inﬂammatory disease that affects the bone and cartilage of
the patient. Vitamin D exerts several immunomodulatory
effects and thus may play a role in the course of autoimmune
diseases.6 A considerable association between VD insufﬁ-
ciency and an increased occurrence of autoimmune disorders
has been determined.7 It has been observed that in RA patients
lymphocytes express VDR.8 In cytoplasm hydroxylated formin D receptor gene polymorphism in Pakistani rheumatoid arthritis
003
toward nucleus, where it increases the VD dependent genes
transcription essential in calcium and bone metabolism,9 also
inhibiting T-cell proliferation and the release of Th1 cytokine
and controls.
ele Allele frequencies Statistics
Case
(n  = 100) (%)
Control
(n  = 70) (%)
Odds ratio
(OR) (95% CI)
p-value
 56.0 66.0 0.6556 (0.4375–0.9825) 0.0513
 44.0 34.0
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Fig. 1 – A, Graph showing genotype distribution of VDR polymorphism (rs1544410) in RA cases and healthy controls. B,
Graph showing allelic distribution of VDR polymorphism (rs1544410) in RA cases and healthy controls.
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ruch as IL-2, IFN- and TNF-.10 Various studies have shown
hat the risk of autoimmune diseases have been increased due
o vitamin D deﬁciency, additionally a considerable clinical
mprovement was observed in the VD-treated RA patients.11
n our study VDR gene rs1544410 polymorphism investigation
hows no statistically signiﬁcant differences in genotype and
llele frequencies of RA patients and healthy controls. Our
bservations are in consistence with the ﬁndings of Maalej
t al.1 who  demonstrated no association of the rs1544410
olymorphism with the development of RA in French and
unisian populations. However, this polymorphism was asso-
iated with other autoimmune diseases like type 1 diabetes
T1D) in many  countries, including different populations like
ungary, Japan, Greece, Bangladesh, Taiwan and Chile.12
igniﬁcant association was also found between rs1544410
olymorphism and osteoporosis.13 Furthermore, the studies
ave been conducted on other various autoimmune diseases
ncluding lupus, cirrhosis, hepatitis, Crohn’s, Graves disease
nd multiple sclerosis in relationship with rs1544410 polymor-
hism and the incidence of systemic lupus erythematosus in
apanese and Chinese was found. So the polymorphism can
e investigated in association with other immune diseases.14
olymorphisms in VDR gene have been observed to be associ-
ted in a sex dependent manner, i.e. more  prevalent in females
ffected with RA.15 Sex speciﬁc association with rs1544410 in
ur group has indicated that polymorphism does not effect
n sex dependent manner in case of RA and there is no link of
his polymorphism to the increased incidence of RA among
emales.
Although ﬁnding of this study shows no evidence of
s1544410 association with RA in our group of study, but there
ight be other polymorphisms found that would have been
ecognized as risk factors for RA. There is a need to investigate
ther molecules implicated in the inﬂammatory pathway ofPlease cite this article in press as: John P, et al. Case–control study of vitam
patients. Rev Bras Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2015.07.
A for genetic association with RA pathogenesis. Other poly-
orphisms in the VDR gene may have signiﬁcant association
oward RA, so larger population study is required to delineate
he association.Conﬂicts  of  interest
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